Breaking News Instant updates and real-time market news.

MDCO

The Medicines Co.

$33.49

-1.61 (-4.59%)

11:45
12/02/16
12/02
11:45
12/02/16
11:45

The Medicines Co. management to meet with JPMorgan

Group luncheon to be held in New York on December 2 hosted by JPMorgan.

MDCO The Medicines Co.
$33.49

-1.61 (-4.59%)

11/16/16
NEED
11/16/16
NO CHANGE
Target $98
NEED
Buy
Alnylam price target lowered to $98 from $137 at Needham
Needham analyst Alan Carr lowered his price target for Alnylam (ALNY) to $98 from $137 after the company announced that collaborator Sanofi (SNY) exercised its option to co-develop and co-commercialize fitusiran, with the analyst adjusting his models to reflect Sanofi taking greater share of revenue. He also notes that Alnylam's collaborator The Medicines Co. (MDCO) announced positive Phase 2 PCSK9 results. Carr reiterates a Buy rating on Alnylam's shares.
11/16/16
RBCM
11/16/16
NO CHANGE
RBCM
The Medicines Co. price target raised to $52 from $45 at RBC Capital
RBC Capital analyst Adnan Butt raised his price target on The Medicines Company after it reported Phase 2 data on its inclisiran drug that he views positively. The analyst says that the drug has differentiated efficacy and safety in LDL-C reduction. He thinks that safety questions created an overhang on the stock, but he still believes that the shares should have risen. The analyst believes that additional data due to be released by the company at the end of the year will be positive. He keeps an Outperform rating on the shares.
11/16/16
LEER
11/16/16
NO CHANGE
Target $57
LEER
Outperform
The Medicines Co. price target raised to $57 from $50 at Leerink
Leerink analyst Joseph Schwartz raised his price target for The Medicines Co. to $57 from $50 following the Phase 2 ORION-1 data presentation at the American Heart Association meeting, and after the company provided an extensive walk-through of the safety findings in addition to encouraging efficacy and durability data. The analyst also raised his probability of success for inclisiran to 60% from 50%. He reiterates an Outperform rating on the shares.
11/15/16
PIPR
11/15/16
NO CHANGE
Target $106
PIPR
Overweight
Alnylam selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends using today's selloff in shares of Alnylam Pharmaceuticals (ALNY) as a buying opportunity. Alnylam's partner The Medicine's Company (MDCO) presented today positive interim safety and efficacy data from the Phase II ORION-1 study of inclisiran, but the stock is weak today on one fatal heart attack in the 500mg inclisiran arm unrelated to study drug, Tenthoff tells investors in a research note. The analyst was impressed by the drug's efficacy and reiterates an Overweight rating on Alnylam with a $106 price target. The stock is down 3% to $48.36 in afternoon trading.

TODAY'S FREE FLY STORIES

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

, GOOG

Alphabet

$980.34

7.42 (0.76%)

10:45
07/25/17
07/25
10:45
07/25/17
10:45
Hot Stocks
Analysts stay bullish on Alphabet after earnings with growth seen continuing »

Shares of Google's…

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

GOOG

Alphabet

$980.34

7.42 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.09

0.27 (0.75%)

10:45
07/25/17
07/25
10:45
07/25/17
10:45
Hot Stocks
Breaking Hot Stocks news story on General Motors »

General Motors says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

VRX

Valeant

$17.97

0.43 (2.45%)

10:45
07/25/17
07/25
10:45
07/25/17
10:45
Options
Valeant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 24

    Aug

10:45
07/25/17
07/25
10:45
07/25/17
10:45
General news
Treasury 2-year auction outlook: »

Treasury 2-year auction…

CIT

CIT Group

$48.74

-0.16 (-0.33%)

10:38
07/25/17
07/25
10:38
07/25/17
10:38
Recommendations
CIT Group analyst commentary  »

CIT Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SRPT

Sarepta

$43.95

0.54 (1.24%)

, BIIB

Biogen

$284.70

1.78 (0.63%)

10:35
07/25/17
07/25
10:35
07/25/17
10:35
Periodicals
STAT's Feuerstein puts Sarepta on list of potential targets for Biogen 

Reference Link

SRPT

Sarepta

$43.95

0.54 (1.24%)

BIIB

Biogen

$284.70

1.78 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 25

    Jul

GM

General Motors

$36.10

0.28 (0.78%)

10:35
07/25/17
07/25
10:35
07/25/17
10:35
Hot Stocks
General Motors expects Q3 to be weakest quarter of the year 

Sees recovery in Q4.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

10:34
07/25/17
07/25
10:34
07/25/17
10:34
Hot Stocks
JetBlue plans to update the market at year-end with its fleet review »

Comments provided during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Aug

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

10:34
07/25/17
07/25
10:34
07/25/17
10:34
Hot Stocks
JetBlue achieved $45M of $250M-$300M cost savings expected by FY20 »

JetBlue sees FY17-FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Aug

LLY

Eli Lilly

$82.04

-2.6978 (-3.18%)

10:33
07/25/17
07/25
10:33
07/25/17
10:33
Hot Stocks
Eli Lilly sees drug pricing executive order in second half of 2017 »

Eli Lilly CEO David Ricks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

POWI

Power Integrations

$81.75

0.2 (0.25%)

, AAPL

Apple

$152.09

1.82 (1.21%)

10:32
07/25/17
07/25
10:32
07/25/17
10:32
Hot Stocks
Power Integrations cut to hold after Apple speculation fuels run-up »

The shares of Power…

POWI

Power Integrations

$81.75

0.2 (0.25%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

TSLA

Tesla

$342.52

14.12 (4.30%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Hot Stocks
Tesla Model S 'tops Consumer Reports' ratings' after adding AEB, CR says »

After updating its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

APRN

Blue Apron

$7.49

0.08 (1.08%)

, BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

APRN

Blue Apron

$7.49

0.08 (1.08%)

BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

ELF

e.l.f. Beauty

$26.61

1.21 (4.76%)

GWW

Grainger

$167.84

0.96 (0.58%)

WMC

Western Asset Mortgage

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Aug

  • 10

    Aug

  • 17

    Oct

  • 24

    Jan

UA

Under Armour

$18.21

-0.0485 (-0.27%)

, UAA

Under Armour

$20.29

0.02 (0.10%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

UA

Under Armour

$18.21

-0.0485 (-0.27%)

UAA

Under Armour

$20.29

0.02 (0.10%)

SNAP

Snap

$13.73

-0.355 (-2.52%)

CYTX

Cytori Therapeutics

$0.48

-0.6301 (-56.77%)

LULU

lululemon

$62.02

0.08 (0.13%)

POWI

Power Integrations

$81.75

0.2 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 10

    Aug

  • 13

    Sep

MDLZ

Mondelez

$43.75

-0.28 (-0.64%)

, BIG

Big Lots

$49.66

2.1 (4.42%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

MDLZ

Mondelez

$43.75

-0.28 (-0.64%)

BIG

Big Lots

$49.66

2.1 (4.42%)

WERN

Werner

$29.20

-0.35 (-1.18%)

TEAM

Atlassian

$36.41

0.66 (1.85%)

DSW

DSW

$17.35

0.87 (5.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Aug

  • 08

    Aug

  • 21

    Aug

  • 25

    Sep

WBA

Walgreens Boots Alliance

$79.60

0.7 (0.89%)

10:30
07/25/17
07/25
10:30
07/25/17
10:30
Hot Stocks
Walgreens to bring nearly 500 jobs to Chandler, Arizona »

Walgreens announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

FCX

Freeport McMoRan

$14.38

1.415 (10.92%)

10:30
07/25/17
07/25
10:30
07/25/17
10:30
Options
Freeport McMoran options active after earnings »

Freeport McMoran options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:30
07/25/17
07/25
10:30
07/25/17
10:30
General news
Treasury Action: yields resumed their rise »

Treasury Action: yields…

SVU

Supervalu

$3.56

0.305 (9.38%)

10:28
07/25/17
07/25
10:28
07/25/17
10:28
Hot Stocks
Supervalu says FY18 base adjusted EBITDA view same ex-Unified contibution »

Sees adjusted EBITDA with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GM

General Motors

$35.90

0.0845 (0.24%)

10:27
07/25/17
07/25
10:27
07/25/17
10:27
Hot Stocks
Breaking Hot Stocks news story on General Motors »

GM CFO says 'very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:25
07/25/17
07/25
10:25
07/25/17
10:25
General news
U.S. Richmond Fed manufacturing index rose 3 points to 14 in July »

U.S. Richmond Fed…

CACQ

Caesars Acquisition

$20.45

0.3 (1.49%)

, CZR

Caesars

$12.90

0.2 (1.57%)

10:25
07/25/17
07/25
10:25
07/25/17
10:25
Conference/Events
Caesars to host special shareholder meeting »

Special Shareholder…

CACQ

Caesars Acquisition

$20.45

0.3 (1.49%)

CZR

Caesars

$12.90

0.2 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 03

    Aug

SVU

Supervalu

$3.56

0.31 (9.54%)

, AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

10:24
07/25/17
07/25
10:24
07/25/17
10:24
Hot Stocks
Breaking Hot Stocks news story on Supervalu, Amazon.com, Whole Foods »

Supervalu sees retail…

SVU

Supervalu

$3.56

0.31 (9.54%)

AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

WFM

Whole Foods

$41.67

-0.04 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

FCX

Freeport McMoRan

$14.28

1.315 (10.15%)

10:22
07/25/17
07/25
10:22
07/25/17
10:22
Hot Stocks
Freeport McMoRan sees 2018 consolidated copper sales of 3.85B pounds »

Freeport sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GM

General Motors

$35.91

0.09 (0.25%)

10:20
07/25/17
07/25
10:20
07/25/17
10:20
Hot Stocks
GM sees North America EBIT adjusted margins of 10%+ for FY17 »

CEO Mary Barra says Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.